Close Menu

NEW YORK – Chembio Diagnostics said on Friday that the US Food and Drug Administration has provided premarket approval for the firm's DPP HIV-Syphilis System.

The system includes the multiplex Dual Path Platform (DPP) HIV-Syphilis assay and the DPP Micro Reader optical analyzer. It will be offered in the US immediately as a result of the FDA approval, the Hauppauge, New York-based company said.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.